The role of immune checkpoint inhibitors (ICI) in the treatment of metastatic non-small cell lung carcinoma in the elderly

被引：2
|
作者：
Chan, Johan [1 ]
Kanesvaran, Ravindran [1 ]
机构：
[1] Natl Canc Ctr Singapore, 11 Hosp Dr, Singapore 169610, Singapore
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
DECISION-MAKING; POOLED ANALYSIS; OPEN-LABEL; DOCETAXEL; PEMBROLIZUMAB; ATEZOLIZUMAB; CHEMOTHERAPY; MULTICENTER; NIVOLUMAB; AGE;
D O I：
10.21037/atm.2019.12.76
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
    Nicos, Marcin
    Krawczyk, Pawel
    Crosetto, Nicola
    Milanowski, Janusz
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [2] Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
    Kuo, Chih-Hsi Scott
    Wang, Chin-Chou
    Huang, Yu-Chen
    Pavlidis, Stelios
    Liu, Chien-Ying
    Ko, How-Wen
    Chung, Fu-Tsai
    Lin, Tin-Yu
    Wang, Chih-Liang
    Guo, Yi-Ke
    Yang, Cheng-Ta
    THORACIC CANCER, 2019, 10 (05) : 1158 - 1166
  • [3] The Checkpoint Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
    Hirsh, Vera
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [4] Monocytes and neutrophils as a predictive marker of response to immune checkpoint inhibitors (ICI) in metastatic non-small cell lung cancer (mNSCLC).
    Parikh, Kaushal
    Kumar, Arun
    Ahmed, Jibran
    Anwar, Asad
    Puccio, Carmelo
    Chun, Hoo Geun
    Fanucchi, Michael Paul
    Lim, Seah
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] The role of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Pistamaltzian, Nikolaos F.
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 435 - 447
  • [6] The Role of Angiogenesis Inhibitors in the Era of Immune Checkpoint Inhibitors and Targeted Therapy in Metastatic Non-Small Cell Lung Cancer
    Perdrizet, Kirstin
    Leighl, Natasha B.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (03)
  • [7] The Role of Angiogenesis Inhibitors in the Era of Immune Checkpoint Inhibitors and Targeted Therapy in Metastatic Non-Small Cell Lung Cancer
    Kirstin Perdrizet
    Natasha B. Leighl
    Current Treatment Options in Oncology, 2019, 20
  • [8] Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer
    Bote, Helena
    Mesas, Andres
    Baena, Javier
    Herrera, Mercedes
    Paz-Ares, Luis
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (03) : 289 - 300
  • [9] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [10] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
12345